Abacus FCF Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Abacus FCF Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell
2023 Q4	$2.01M	Buy
2023 Q3	$961K	Buy
2022 Q2	–	Sell
2022 Q1	$842K	Buy
2021 Q3	–	Sell
2021 Q2	$894K	Sell
2021 Q1	$1.06M	Sell
2020 Q4	$1.17M	Sell
2020 Q3	$1.47M	Buy
2020 Q2	$1.01M	Buy